Therapeutic Areas
Clinical Depth Across Major Research Specialties
BioHub supports Phase I–IV clinical development across a broad range of therapeutic areas, combining specialty medical expertise with indication-relevant patient populations and protocol-specific research capabilities.
Our strongest research programs reflect areas in which our investigator network has established clinical-trial experience and continued access to relevant patient populations.
30+ Investigators
Multiple Specialties
Phase I-IV — Study Support
Patient-Centric — Approach
Phase I
Early Development
Safety & PK/PD
Phase I
Early Development
Safety & PK/PD
Phase I
Early Development
Safety & PK/PD
Phase I
Early Development
Safety & PK/PD
ESTABLISHED RESEARCH STRENGTHS
Areas of Demonstrated Trial Experience
These therapeutic areas represent established areas of BioHub research activity, including experience across multiple clinical trials within our investigator network.
RHEUMATOLOGY & IMMUNOLOGY
- Rheumatoid arthritis
- Psoriatic arthritis
- Gout
- Lupus
- Osteoarthritis
- Autoimmune and inflammatory disorders
Ophthalmology
- Thyroid eye disease
- Dry eye disease
- Retinal disorders
- Glaucoma
- Age-related eye disease
- Inflammatory ophthalmic conditions
Cardiovascular
- Heart failure
- Hypertension
- Dyslipidemia
- Coronary artery disease
- Atrial fibrillation
- Cardiovascular risk
- Cardiometabolic disease
Obesity & Metabolic Medicine
- Obesity
- Weight management
- Cardiometabolic risk
- Metabolic syndrome
- Obesity-associated conditions
- Cardiometabolic risk
Endocrinology & Diabetes
- Type 1 diabetes
- Type 2 diabetes
- Endocrine disorders
- Thyroid disease
- Dyslipidemia
- Metabolic disease
Psychiatry
- Major depressive disorder (MDD)
- Bipolar disorder
- Anxiety disorders
- CNS disorders
- Psychiatric rating scales
- Long-term follow-up
Additional Therapeutic Capabilities
Latest Case Studies
